Sarah Cannon Research Institute
Harbinger Health Joins Emerging Multi-Cancer Screening Arena With Tech Focused On Oncogenesis
Premium
The company recently signed a partnership with Sarah Cannon to conduct a 10,000-patient clinical study to further validate its experimental assay.
Foundation Medicine, Sarah Cannon Partner on Genomic Profiling for Cancer Clinical Trials
Under the agreement, researchers can use Foundation Medicine's assays to select patients eligible for Sarah Cannon Research Institute's clinical studies.